Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

85.74
Delayed Data
As of Oct 20
 -0.42 / -0.49%
Today’s Change
66.93
Today|||52-Week Range
86.90
+17.71%
Year-to-Date
Roche (RHHBY) Reports Sales Numbers for First 9 Months
Oct 20 / Zacks.com - Paid Partner Content
What's in the Cards for Novartis (NVS) This Earnings Season?
Oct 18 / Zacks.com - Paid Partner Content
Gilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval
Oct 20 / Zacks.com - Paid Partner Content
Aerie (AERI) Up on FDA Review Committee Result for Rhopressa
Oct 17 / Zacks.com - Paid Partner Content
Cancer Treatment Update: Second Gene Therapy Receives Approval
Oct 20 / Zacks.com - Paid Partner Content
Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks
Oct 17 / Zacks.com - Paid Partner Content
Glaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again?
Oct 20 / Zacks.com - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
What's in the Cards for Amgen (AMGN) this Earnings Season?
Oct 20 / Zacks.com - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
Conatus' Liver Disease Drug Gets Orphan Drug Tag in the EU
Oct 20 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY), TARGET Extend Partnership for NASH Study
Oct 13 / Zacks.com - Paid Partner Content
Can ImmunoGen's Key Pipeline Cancer Candidate Drive Growth?
Oct 19 / Zacks.com - Paid Partner Content
Lilly's Verzenio Gets Priority Review in First-Line Setting
Oct 13 / Zacks.com - Paid Partner Content
Conatus Entrusts Keith W. Marshall With Key Management Roles
Oct 19 / Zacks.com - Paid Partner Content
Non-Alcoholic Steatohepatitis 2017 Progress Update
Oct 12 / Zacks.com - Paid Partner Content
Teva Submits BLA to FDA for Migraine Candidate Fremanezumab
Oct 19 / Zacks.com - Paid Partner Content
Lilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study
Oct 11 / Zacks.com - Paid Partner Content
Novartis Reports Positive Results on Thrombocytopenia Drug
Oct 19 / Zacks.com - Paid Partner Content
5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings
Oct 10 / Zacks.com - Paid Partner Content
Gilead Stock Climbs as FDA Approves Lymphoma Cancer Therapy Drug Yescarta
Oct 19 / TheStreet.com - Paid Partner Content
Roche (RHHBY) Receives FDA Approval For Cobas Zika Test
Oct 09 / Zacks.com - Paid Partner Content
What to Expect from Big Pharmas After J&J's Solid Q3 Results?
Oct 18 / Zacks.com - Paid Partner Content